You are here: Home > Therapeutics (former) > Endocannabinoid Degradation and Human Fertility
J Cannabis Ther 2002(3/4):035-47
Endocannabinoids
Endocannabinoid Degradation and Human Fertility
Author
M. Bari, N. Battista, A. Cartoni, G. D'Arcangelo, M. Maccarrone
Abstract
Anandamide (AEA) impairs mouse pregnancy and embryo development. Here, we overview the role of AEA in sexual function, focusing on AEA degradation during human pregnancy. Human peripheral lymphocytes express the AEA-hydrolyzing enzyme fatty acid amide hydrolase (FAAH), which decreases in miscarrying women. FAAH is regulated by progesterone and Th1/Th2 cytokines, whereas the AEA transporter and the AEA binding cannabinoid receptors are not affected. Taken together, our results appear to add the endocannabinoids to the hormone-cytokine array involved in the control of human pregnancy, and suggest that FAAH might be a useful diagnostic marker for large scale, routine monitoring of gestation in humans.
Keywords
Anandamide, cytokines, endocannabinoids, human fertility, sex hormones
Online Events 2020
Please find all information of IACM Online Events including free videos of the webinars here.
Conference 2022
The 12th IACM Conference on Cannabinoids in Medicine will be we be held on 20 and 21 October 2022 together with the Swiss SSCM in Basel/Switzerland.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.